Understanding how T cells help B cells produce high affinity antibodies
Defining the role of T cell help in germinal centers by intercellular enzymatic labeling
['FUNDING_R01'] · ROCKEFELLER UNIVERSITY · NIH-10885077
This study is looking at how certain immune cells help other cells make strong antibodies that fight infections, and it's aimed at finding ways to improve vaccines and treatments for autoimmune diseases.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | ROCKEFELLER UNIVERSITY (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-10885077 on ClinicalTrials.gov |
What this research studies
This research investigates the mechanisms by which T follicular helper (Tfh) cells assist B cells in generating high affinity antibodies, which are crucial for effective immune responses against infections and diseases. The study employs advanced techniques to label and track interactions between Tfh cells and B cells in germinal centers, aiming to clarify how Tfh cells selectively support B cells that produce the most effective antibodies. By understanding these processes, the research seeks to uncover insights that could improve vaccine development and treatments for autoimmune diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with autoimmune diseases or those seeking improved vaccine responses.
Not a fit: Patients who do not have immune-related conditions or are not interested in vaccination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to enhanced vaccine strategies and therapies for autoimmune diseases by improving our understanding of antibody production.
How similar studies have performed: Previous research has shown promising results in understanding T cell and B cell interactions, indicating that this approach has potential for significant advancements.
Where this research is happening
NEW YORK, UNITED STATES
- ROCKEFELLER UNIVERSITY — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VICTORA, GABRIEL D — ROCKEFELLER UNIVERSITY
- Study coordinator: VICTORA, GABRIEL D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus